0001104659-21-150001.txt : 20211215 0001104659-21-150001.hdr.sgml : 20211215 20211215161910 ACCESSION NUMBER: 0001104659-21-150001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211213 FILED AS OF DATE: 20211215 DATE AS OF CHANGE: 20211215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McBarron Paul CENTRAL INDEX KEY: 0001357397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 211494417 MAIL ADDRESS: STREET 1: C/O CYCLACEL PHARMACEUTICALS, INC. STREET 2: 200 CONNELL DRIVE, SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2135363d2_4.xml OWNERSHIP DOCUMENT X0306 4 2021-12-13 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001357397 McBarron Paul C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 1 0 0 See Remarks Stock Option (right to buy) 3.45 2021-12-13 4 A 0 100000 0 A 2031-12-13 Common Stock 100000 100000 D These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis. These securities were granted as part of the Issuer's annual compensation review to executive officers. E. VP, Fin, CFO, COO and Secretary /s/ Paul McBarron 2021-12-15